Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein.
Hypertension is a major cause for hypertrophic remodelling of the myocardium. Agonistic autoantibodies to extracellular loops of the alpha(1)-adrenergic receptor (alpha(1)-AR) have been identified in patients with arterial hypertension. However, intracellular reactions elicited by these agonistic antibodies remain elusive. An anti-peptide antibody (anti-alpha(1)) was generated against the second extracellular loop of the alpha(1)-AR that bound to its peptide epitope with high affinity (K (D) approximately 50 nM). We studied anti-alpha(1) effects on intracellular calcium (Ca(i)), a key factor in cellular remodelling, and receptor-mediated cardiac protein phosphorylation. Anti-alpha(1) induced pronounced but transient increases in Ca(i) in CHO cells expressing the human alpha(1)-AR (CHO-alpha(1)) and in neonatal cardiomyocytes. Preincubation experiments failed to demonstrate a tonic effect of anti-alpha(1) on Ca(i). However, preincubation with the antibody attenuated the effect of the alpha(1)-AR antagonist prazosin. In neonatal cardiomyocytes anti-alpha(1) induced a robust phosphorylation of a 15-kDa protein that is involved in alpha(1)-AR signalling. Our data support the notion that elevation of Ca(i) is a general feature of agonistic antibodies' action and constitute an important pathogenic component of hypertension-associated autoantibodies. Furthermore, we suggest that agonistic antibodies to the alpha(1)-AR contribute to hypertrophic remodelling of cardiac myocytes, and that the cardiac 15-kDa protein is a relevant downstream target of their action.
Karczewski
Peter
P
ERDE eV, Campus Berlin-Buch, Building 55 (OCVH), Robert-Rössle-Strasse 10, 13125, Berlin, Germany. karczewski@aak-diagnostik.de
Haase
Hannelore
H
Hempel
Petra
P
Bimmler
Marion
M
D058646:Adrenergic alpha-1 Receptor Agonists; D000818:Animals; D000831:Animals, Newborn; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D001323:Autoantibodies; D016466:CHO Cells; D020013:Calcium Signaling; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D032383:Myocytes, Cardiac / Q000737:chemistry*; D010766:Phosphorylation; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics / Q000502:physiology*; D014162:Transfection
D058646:Adrenergic alpha-1 Receptor Agonists; D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D011506:Proteins; D018340:Receptors, Adrenergic, alpha-1
Lancet. 1994 Dec 17;344(8938):1660-3
7527885
Am J Cardiol. 1970 Mar;25(3):292-9
5443907
Circulation. 2000 May 23;101(20):2382-7
10821814
Hypertension. 1997 Feb;29(2):678-82
9040456
J Biol Chem. 1986 Apr 15;261(11):4860-7
2420794
Circ Res. 2005 Aug 5;97(3):252-9
16002746
Trends Pharmacol Sci. 2007 Aug;28(8):374-81
17629959
Circulation. 2004 Sep 21;110(12):1612-9
15381659
Am J Physiol. 1991 Mar;260(3 Pt 2):H953-6
1848051
Biomed Biochim Acta. 1987;46(8-9):S634-9
2449194
FEBS Lett. 1996 Dec 9;399(1-2):188-91
8980149
Biochem J. 1990 Feb 15;266(1):115-22
2155603
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H96-106
16055523
Cell Mol Immunol. 2008 Jun;5(3):209-17
18582403
Circ Res. 1989 Jan;64(1):97-103
2535798
Sci Signal. 2008 Jun 24;1(25):pe31
18577756
PLoS One. 2008;3(11):e3742
19011682
Pharmacol Rev. 1999 Dec;51(4):651-90
10581327
Eur J Heart Fail. 2007 Apr;9(4):329-35
17257893
Mol Pharmacol. 2000 Aug;58(2):373-9
10908305
Nat Med. 2008 Aug;14(8):855-62
18660815
Hypertens Res. 2002 Jul;25(4):641-6
12358154
J Mol Cell Cardiol. 1995 Jan;27(1):397-406
7539084
Can J Physiol Pharmacol. 2003 Mar;81(3):234-46
12733822
Trends Endocrinol Metab. 2003 Apr;14(3):107-13
12670735
Acta Pharmacol Sin. 2007 Jul;28(7):968-74
17588332
Biochem Pharmacol. 2007 Apr 15;73(8):1097-106
17141737
J Am Soc Nephrol. 2000 Jul;11(7):1188-1198
10864574
Ann N Y Acad Sci. 2007 Mar;1099:119-34
17446450
Clin Immunol. 2005 Feb;114(2):164-73
15639650
J Biol Chem. 1991 Jun 15;266(17):11126-30
1710217
J Mol Cell Cardiol. 2001 Aug;33(8):1515-25
11448139
J Biol Chem. 1985 Mar 25;260(6):3860-7
2982878
J Clin Invest. 1990 Nov;86(5):1658-63
1700798
Mol Cell Biochem. 2001 Aug;224(1-2):69-79
11693201
Circ Res. 2005 Sep 16;97(6):558-65
16100047
J Am Coll Cardiol. 2000 Oct;36(4):1280-7
11028484
Clin Exp Immunol. 1994 Jul;97(1):146-51
7518367